In addition, the dual-drug loaded liposomes increased tumor targeting and intratumoral blood oxygen saturation, indicating that the tumor reoxygenation effect of MET promotes its synergistic effect with DOX to combat MCF7/ADR xenografts. Here, MET is linked to neoplasm.